Study of ovarian effectors, pregnanediol, gonadotrophins, 17-ketosteroids, 17-hydroxysteroids, and proteic iodine, during therapy with clomiphene.
D015065:17-Hydroxycorticosteroids / Q000652:urine*; D015068:17-Ketosteroids / Q000652:urine*; D000568:Amenorrhea / Q000188:drug therapy*; D001831:Body Temperature; D002582:Cervix Mucus; D002996:Clomiphene / Q000627:therapeutic use*; D004717:Endometrium; D005260:Female; D006065:Gonadotropins, Pituitary / Q000652:urine*; D006801:Humans; D007455:Iodine; D010053:Ovary / Q000187:drug effects; D010060:Ovulation / Q000187:drug effects; D011247:Pregnancy; D011276:Pregnanediol / Q000652:urine*; D013960:Thyroid Function Tests; D014626:Vaginal Smears
D015065:17-Hydroxycorticosteroids; D015068:17-Ketosteroids; D006065:Gonadotropins, Pituitary; D002996:Clomiphene; D007455:Iodine; D011276:Pregnanediol